Bio-Rad Laboratories Q3 Adj. EPS $2.65 Beats $2.23 Estimate, Sales $656.400M Beat $649.950M Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings Beats
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $2.23 by 18.83 percent. This is a 17.26 percent increase over earnings of $2.26 per share from
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $2.23 by 18.83 percent. This is a 17.26 percent increase over earnings of $2.26 per share from the same period last year. The company reported quarterly sales of $656.400 million which beat the analyst consensus estimate of $649.950 million by 0.99 percent. This is a 0.52 percent increase over sales of $653.000 million the same period last year.